_version_ 1785061404462546944
author Oosting, S.F.
van der Veldt, A.A.M.
Fehrmann, R.S.N.
Bhattacharya, A.
van Binnendijk, R.S.
GeurtsvanKessel, C.H.
Dingemans, A.-M.C.
Smit, E.F.
Hiltermann, T.J.N.
den Hartog, G.
Jalving, M.
Westphal, T.T.
de Wilt, F.
Ernst, S.M.
Boerma, A.
van Zijl, L.
Rimmelzwaan, G.F.
Kvistborg, P.
van Els, C.A.C.M.
Rots, N.Y.
van Baarle, D.
Haanen, J.B.A.G.
de Vries, E.G.E.
author_facet Oosting, S.F.
van der Veldt, A.A.M.
Fehrmann, R.S.N.
Bhattacharya, A.
van Binnendijk, R.S.
GeurtsvanKessel, C.H.
Dingemans, A.-M.C.
Smit, E.F.
Hiltermann, T.J.N.
den Hartog, G.
Jalving, M.
Westphal, T.T.
de Wilt, F.
Ernst, S.M.
Boerma, A.
van Zijl, L.
Rimmelzwaan, G.F.
Kvistborg, P.
van Els, C.A.C.M.
Rots, N.Y.
van Baarle, D.
Haanen, J.B.A.G.
de Vries, E.G.E.
author_sort Oosting, S.F.
collection PubMed
description
format Online
Article
Text
id pubmed-10284446
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102844462023-06-22 Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors Oosting, S.F. van der Veldt, A.A.M. Fehrmann, R.S.N. Bhattacharya, A. van Binnendijk, R.S. GeurtsvanKessel, C.H. Dingemans, A.-M.C. Smit, E.F. Hiltermann, T.J.N. den Hartog, G. Jalving, M. Westphal, T.T. de Wilt, F. Ernst, S.M. Boerma, A. van Zijl, L. Rimmelzwaan, G.F. Kvistborg, P. van Els, C.A.C.M. Rots, N.Y. van Baarle, D. Haanen, J.B.A.G. de Vries, E.G.E. ESMO Open Correspondence Elsevier 2023-06-21 /pmc/articles/PMC10284446/ /pubmed/37450950 http://dx.doi.org/10.1016/j.esmoop.2023.101599 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correspondence
Oosting, S.F.
van der Veldt, A.A.M.
Fehrmann, R.S.N.
Bhattacharya, A.
van Binnendijk, R.S.
GeurtsvanKessel, C.H.
Dingemans, A.-M.C.
Smit, E.F.
Hiltermann, T.J.N.
den Hartog, G.
Jalving, M.
Westphal, T.T.
de Wilt, F.
Ernst, S.M.
Boerma, A.
van Zijl, L.
Rimmelzwaan, G.F.
Kvistborg, P.
van Els, C.A.C.M.
Rots, N.Y.
van Baarle, D.
Haanen, J.B.A.G.
de Vries, E.G.E.
Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors
title Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors
title_full Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors
title_fullStr Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors
title_full_unstemmed Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors
title_short Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors
title_sort factors associated with long-term antibody response after covid-19 vaccination in patients treated with systemic treatment for solid tumors
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284446/
https://www.ncbi.nlm.nih.gov/pubmed/37450950
http://dx.doi.org/10.1016/j.esmoop.2023.101599
work_keys_str_mv AT oostingsf factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT vanderveldtaam factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT fehrmannrsn factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT bhattacharyaa factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT vanbinnendijkrs factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT geurtsvankesselch factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT dingemansamc factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT smitef factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT hiltermanntjn factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT denhartogg factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT jalvingm factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT westphaltt factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT dewiltf factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT ernstsm factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT boermaa factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT vanzijll factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT rimmelzwaangf factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT kvistborgp factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT vanelscacm factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT rotsny factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT vanbaarled factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT haanenjbag factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors
AT devriesege factorsassociatedwithlongtermantibodyresponseaftercovid19vaccinationinpatientstreatedwithsystemictreatmentforsolidtumors